A SIRP-ALPHA BINDING CHIMERIC PROTEIN
Applicants:
- Novo Nordisk (Denmark) [NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD]
Abstract
The present disclosure provides chimeric proteins comprising an extracellular domain, a transmembrane domain and a linker between said extracellular domain and said transmembrane domain, cells comprising said chimeric proteins, cell compositions, pharmaceutical products and preparation process thereof. The cells, cell compositions and pharmaceutical products are useful in the field of cell therapy.
Patent Family Records (1)
A SIRP-ALPHA BINDING CHIMERIC PROTEIN
NOVO NORDISK AS, Novo Nordisk (Denmark) YANG CHE
2024, WO-2024008979-A1